Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 62.95
+0.50 (0.80%)
May 27, 2026, 4:09 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 12.52 billion as of May 27, 2026.
Market Cap
12.52B
Enterprise Value
11.11B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.95
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 12.52B, a decrease of -3.50%. That is a compound annual growth rate of -4.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 12.42B | 22.45% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metis TechBio | 19.45B |
| Keymed Biosciences | 18.50B |
| TransThera Sciences (Nanjing) | 17.31B |
| Ascletis Pharma | 16.56B |
| Zai Lab | 16.38B |
| Ascentage Pharma Group International | 15.33B |
| CStone Pharmaceuticals | 12.82B |
| Everest Medicines | 11.17B |